Some immigrant advocates are criticizing a U.S. policy that requires female immigrants ages 11 to 26 to receive Merck & Co.'s Gardasil, a cervical cancer vaccine, saying it forces such individuals to shoulder a costly burden. The requirement, which took effect Aug. 1, is in accordance with CDC recommendations, a U.S. Citizenship and Immigration Services spokeswoman said. Gardasil's inclusion on the list of mandatory vaccines may be reviewed, a government official said.
Published in Brief: